401 related articles for article (PubMed ID: 22530690)
21. Recent patents on ocular drug delivery systems.
Conway BR
Recent Pat Drug Deliv Formul; 2008; 2(1):1-8. PubMed ID: 19075892
[TBL] [Abstract][Full Text] [Related]
22. Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery.
Bhattacharjee A; Das PJ; Adhikari P; Marbaniang D; Pal P; Ray S; Mazumder B
Eur J Ophthalmol; 2019 Jan; 29(1):113-126. PubMed ID: 29756507
[TBL] [Abstract][Full Text] [Related]
23. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations.
Almeida H; Amaral MH; Lobão P; Lobo JM
Drug Discov Today; 2014 Apr; 19(4):400-12. PubMed ID: 24120893
[TBL] [Abstract][Full Text] [Related]
24. Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases.
Rajitha P; Gopinath D; Biswas R; Sabitha M; Jayakumar R
Expert Opin Drug Deliv; 2016 Aug; 13(8):1177-94. PubMed ID: 27087148
[TBL] [Abstract][Full Text] [Related]
25. In Situ Gelling Ophthalmic Drug Delivery System: An Overview and Its Applications.
Sheshala R; Kok YY; Ng JM; Thakur RR; Dua K
Recent Pat Drug Deliv Formul; 2015; 9(3):237-48. PubMed ID: 26205681
[TBL] [Abstract][Full Text] [Related]
26. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
[TBL] [Abstract][Full Text] [Related]
27. In situ gelling systems for ocular drug delivery.
Ahmed B; Jaiswal S; Naryal S; Shah RM; Alany RG; Kaur IP
J Control Release; 2024 Jul; 371():67-84. PubMed ID: 38768662
[TBL] [Abstract][Full Text] [Related]
28. In vitro testing of thiolated poly(aspartic acid) from ophthalmic formulation aspects.
Budai-Szű Cs M; Horvát G; Gyarmati B; Szilágyi BÁ; Szilágyi A; Csihi T; Berkó S; Szabó-Révész P; Mori M; Sandri G; Bonferoni MC; Caramella C; Csányi E
Drug Dev Ind Pharm; 2016 Aug; 42(8):1241-6. PubMed ID: 26556306
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and Characterization of Poly(2-hydroxyethylmethacrylate) Contact Lenses Containing Chitosan Nanoparticles as an Ocular Delivery System for Dexamethasone Sodium Phosphate.
Behl G; Iqbal J; O'Reilly NJ; McLoughlin P; Fitzhenry L
Pharm Res; 2016 Jul; 33(7):1638-48. PubMed ID: 26964548
[TBL] [Abstract][Full Text] [Related]
30. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye.
Nagarwal RC; Kumar R; Pandit JK
Eur J Pharm Sci; 2012 Nov; 47(4):678-85. PubMed ID: 22922098
[TBL] [Abstract][Full Text] [Related]
31. Polysaccharide-Based Nanocarriers for Ocular Drug Delivery.
Formica ML; Calles JA; Palma SD
Curr Pharm Des; 2015; 21(33):4851-68. PubMed ID: 26290208
[TBL] [Abstract][Full Text] [Related]
32. Novel Ocular Drug Delivery Systems: An Update on Microemulsions.
Üstündağ Okur N; Çağlar EŞ; Siafaka PI
J Ocul Pharmacol Ther; 2020; 36(6):342-354. PubMed ID: 32255728
[TBL] [Abstract][Full Text] [Related]
33. A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems.
Andonova VY
Curr Pharm Des; 2016; 22(41):6313-6329. PubMed ID: 27526789
[TBL] [Abstract][Full Text] [Related]
34. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Li J; Tan G; Cheng B; Liu D; Pan W
Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
[TBL] [Abstract][Full Text] [Related]
35. Review of ocular drug delivery.
Sultana Y; Jain R; Aqil M; Ali A
Curr Drug Deliv; 2006 Apr; 3(2):207-17. PubMed ID: 16611007
[TBL] [Abstract][Full Text] [Related]
36. Industrial perspective in ocular drug delivery.
Ali Y; Lehmussaari K
Adv Drug Deliv Rev; 2006 Nov; 58(11):1258-68. PubMed ID: 17079049
[TBL] [Abstract][Full Text] [Related]
37. Gelling hypotonic polymer solution for extended topical drug delivery to the eye.
Kim YC; Shin MD; Hackett SF; Hsueh HT; Lima E Silva R; Date A; Han H; Kim BJ; Xiao A; Kim Y; Ogunnaike L; Anders NM; Hemingway A; He P; Jun AS; McDonnell PJ; Eberhart C; Pitha I; Zack DJ; Campochiaro PA; Hanes J; Ensign LM
Nat Biomed Eng; 2020 Nov; 4(11):1053-1062. PubMed ID: 32895514
[TBL] [Abstract][Full Text] [Related]
38. Chitosan-based gastroretentive floating drug delivery technology: an updated review.
Pahwa R; Saini N; Kumar V; Kohli K
Expert Opin Drug Deliv; 2012 May; 9(5):525-39. PubMed ID: 22444200
[TBL] [Abstract][Full Text] [Related]
39. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
Al-Kassas RS; El-Khatib MM
Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
[TBL] [Abstract][Full Text] [Related]
40. Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery.
Singh RM; Kumar A; Pathak K
Expert Opin Drug Deliv; 2013 Jan; 10(1):115-30. PubMed ID: 23199072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
